Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

Phase 4CompletedNCT00198549

Bausch & Lomb Incorporated40 enrolled

Overview

The purpose of this study is to evaluate Vitrase as an adjuvant to increase absorption and dispersion of other injected anesthetics

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Pain

Interventions

Vitrase (ovine hyaluronidase) LyophilizedDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Scheduled for an ophthalmic surgical procedure Exclusion Criteria: * Known allergy to bee venom

Locations (1)

Cincinnati Eye Institute

Cincinnati, Ohio, United States

Outcomes

Primary Outcomes

To evaluate physician acceptance of efficacy of Vitrase as an adjuvant to increase absorption and dispersion of anesthetics used for ophthalmic surgical procedures

Secondary Outcomes

To determine physician usage of and satisfaction with Vitrase in the 6200 USP unit vial

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.